Citius Pharmaceuticals, Inc. (CTXR) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 19 transactions totaling $15.8M, demonstrating a bullish sentiment with $15.8M in net insider flow. The most recent transaction on Mar 13, 2024 involved a transaction of 48 shares valued at $36.
No significant insider buying has been recorded for CTXR in the recent period.
No significant insider selling has been recorded for CTXR in the recent period.
Based on recent SEC filings, insider sentiment for CTXR is bullish with an Insider Alignment Score of 100/100 and a net flow of $15.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Citius Pharmaceuticals, Inc. (CTXR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading CTXR stock, having executed 19 transactions in the past 90 days. The most active insider is Leonard L. Mazur (Executive), who has made 10 transactions totaling $18.9M.
Get notified when executives and directors at CTXR file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 13, 2024 | Myron Holuka Eugene | Executive | Payment | 48 | $0.75 | $36 | |
| Mar 13, 2024 | Myron Holuka Eugene | Executive | Option Exercise | 2,415 | $0.02 | $48 | |
| Mar 4, 2024 | Webb Carol | Executive | Payment | 236 | $0.77 | $182 | |
| Mar 4, 2024 | Webb Carol | Executive | Option Exercise | 12,071 | $0.02 | $241 | |
| Sep 27, 2019 | Z. Holubiak Myron | Executive | Purchase | 558,597 | $0.90 | $502.7K | Large |
| Sep 27, 2019 | L. Mazur Leonard | Executive | Purchase | 2,234,700 | $0.90 | $2.0M | Large |
| Apr 3, 2019 | Z. Holubiak Myron | Executive | Purchase | 129,450 | $1.55 | $200.6K | |
| Apr 3, 2019 | L. Mazur Leonard | Executive | Purchase | 1,165,048 | $1.55 | $1.8M | Large |
| Aug 13, 2018 | Z. Holubiak Myron | Executive | Purchase | 784,314 | $1.28 | $1.0M | Large |
| Aug 13, 2018 | L. Mazur Leonard | Executive | Purchase | 3,137,255 | $1.28 | $4.0M | Large |
| Mar 29, 2018 | L. Mazur Leonard | Executive | Purchase | 167,504 | $2.99 | $500.8K | Large |
| Mar 28, 2018 | Z. Holubiak Myron | Executive | Purchase | 2,915 | $3.09 | $9.0K | |
| Dec 19, 2017 | L. Mazur Leonard | Executive | Purchase | 213,106 | $4.69 | $999.5K | Large |
| Aug 24, 2017 | L. Mazur Leonard | Executive | Purchase | 11,000 | $2.68 | $29.5K | |
| Aug 8, 2017 | L. Mazur Leonard | Executive | Conversion | 1,547,067 | $3.09 | $4.8M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 12 | $15.8M | 76.8% |
Conversion(C) | 1 | $4.8M | 23.2% |
Exercise(M) | 2 | $290 | 0.0% |
Payment(F) | 2 | $218 | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Insiders at Citius Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 4 insiders making 19 transactions totaling $15.8M in purchases versus $0 in sales, the net buying activity of $15.8M signals strong executive confidence. Leonard L. Mazur (Executive) leads the buying activity with $18.9M in transactions across all time.